PRINCIPAL FINANCIAL GROUP INC
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1126328
DES MOINES, IA
Position in INDV
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$23,389,680
New position
Shares Held
767,378
first reported quarter
Ownership
0.629%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $470,953,958 across 26 Drug Manufacturers - Specialty & Generic names. INDV ranks #9 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
552,331 | $65,291,046 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
101,692 | $60,301,321 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
1,295,028 | $42,826,575 | |
| 4 | ALKS |
Alkermes plc.
|
958,016 | $33,875,445 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,386,907 | $33,188,684 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
238,161 | $31,375,329 | |
| 7 | HLN |
Haleon plc
|
2,803,530 | $28,063,335 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,282,266 | $26,619,841 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,389,680 | 767,378 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||